Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Horizon Therapeutics Publ...

    NASDAQ: HZNP · Real-Time Price · USD
    116.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Horizon Therapeutics Public Statistics

    Share Statistics

    Horizon Therapeutics Public has 228.74M shares outstanding. The number of shares has increased by -0.39% in one year.

    Shares Outstanding

    n/a
    		 228.74M

    Shares Change (YoY)

    n/a
    		 -0.39%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 211.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 490

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 50 and the forward PE ratio is null. Horizon Therapeutics Public's PEG ratio is -13.17.

    PE Ratio

    n/a
    		 50

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 7.18

    Forward PS

    n/a
    		 5.6

    PB Ratio

    n/a
    		 5.14

    P/FCF Ratio

    n/a
    		 23.04

    PEG Ratio

    n/a
    		 -13.17
    Financial Ratio History

    Enterprise Valuation

    Horizon Therapeutics Public has an Enterprise Value (EV) of 26.28B.

    EV / Sales

    n/a
    		 7.24

    EV / EBITDA

    n/a
    		 23.58

    EV / EBIT

    n/a
    		 20.89

    EV / FCF

    n/a
    		 23.23

    Financial Position

    The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.51.

    Current Ratio

    n/a
    		 3.85

    Quick Ratio

    n/a
    		 3.67

    Debt / Equity

    n/a
    		 0.51

    Debt / EBITDA

    n/a
    		 2.3

    Debt / FCF

    n/a
    		 2.26

    Interest Coverage

    n/a
    		 7.38

    Financial Efficiency

    Return on Equity is 10.28% and Return on Invested Capital is 7.47%.

    Return on Equity

    n/a
    		 10.28%

    Return on Assets

    n/a
    		 5.72%

    Return on Invested Capital

    n/a
    		 7.47%

    Revenue Per Employee

    n/a
    		 $1,657,097.72

    Profits Per Employee

    n/a
    		 $238,119.63

    Employee Count

    n/a
    		 2,190

    Asset Turnover

    n/a
    		 0.4

    Inventory Turnover

    n/a
    		 5.43

    Taxes

    Income Tax

    n/a
    		 5.45M

    Effective Tax Rate

    n/a
    		 1.04%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.01, so Horizon Therapeutics Public's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.01

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 111.11

    200-Day Moving Average

    n/a
    		 108.3

    Relative Strength Index (RSI)

    n/a
    		 83.96

    Average Volume (20 Days)

    n/a
    		 23,917,757

    Income Statement

    In the last 12 months, Horizon Therapeutics Public had revenue of 3.63B and earned 521.48M in profits. Earnings per share was 2.28.

    Revenue

    n/a
    		 3.63B

    Gross Profit

    n/a
    		 2.71B

    Operating Income

    n/a
    		 617.41M

    Net Income

    n/a
    		 521.48M

    EBITDA

    n/a
    		 1.11B

    EBIT

    n/a
    		 610.64M

    Earnings Per Share (EPS)

    n/a
    		 2.28
    Full Income Statement

    Balance Sheet

    The company has 2.35B in cash and 2.56B in debt, giving a net cash position of -210M.

    Cash & Cash Equivalents

    n/a
    		 2.35B

    Total Debt

    n/a
    		 2.56B

    Net Cash

    n/a
    		 -210M

    Retained Earnings

    n/a
    		 590.01M

    Total Assets

    n/a
    		 9.3B

    Working Capital

    n/a
    		 3B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.26B and capital expenditures -126.28M, giving a free cash flow of 1.13B.

    Operating Cash Flow

    n/a
    		 1.26B

    Capital Expenditures

    n/a
    		 -126.28M

    Free Cash Flow

    n/a
    		 1.13B

    FCF Per Share

    n/a
    		 4.94
    Full Cash Flow Statement

    Margins

    Gross margin is 74.64%, with operating and profit margins of 17.01% and 14.37%.

    Gross Margin

    n/a
    		 74.64%

    Operating Margin

    n/a
    		 17.01%

    Pretax Margin

    n/a
    		 14.52%

    Profit Margin

    n/a
    		 14.37%

    EBITDA Margin

    n/a
    		 30.71%

    EBIT Margin

    n/a
    		 17.01%

    FCF Margin

    n/a
    		 31.18%

    Dividends & Yields

    HZNP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 2%

    FCF Yield

    n/a
    		 4.34%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for HZNP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.08

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist